TACROLIMUS
| Brand name | PROGRAF |
|---|---|
| Active ingredient | TACROLIMUS |
| Strength | EQ 5MG BASE/ML |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Modality | Small molecule |
| FDA approval | April 1994 |
| Marketing status | RX |
| Code | Expires |
|---|---|
| ODE-360 | July 2028 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.